Colestin Tablets (Simvastatin)
Simvastatin 20mg
Tablet · Prescription medication
Daehwa Pharmaceutical Co., Ltd.
MFDS item code 200201767 · Notified 2002.10.15
This product's status changed to Approval withdrawn on 2024.11.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hyperlipidemia and pediatric familial hypercholesterolemia; prevention of cardiovascular disease
This medication is highly effective in reducing the risk of cardiovascular diseases. It can reduce the risk of coronary events and cardiovascular mortality in adult patients with a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular diseases, and lower the risk of non-fatal myocardial infarction and stroke. It also decreases the risk of complications that may occur after coronary and non-coronary vascular procedures. Additionally, this drug is helpful in treating hyperlipidemia, effectively lowering total cholesterol and LDL cholesterol levels in patients with primary and mixed dyslipidemia, while increasing good HDL cholesterol. It is especially an important treatment option for patients with familial hypercholesterolemia and can be used in conjunction with or as an alternative to other therapies, and is used as a dietary supplement in pediatric patients. This medication helps improve cardiovascular health and manage hyperlipidemia.
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial starting dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial starting dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Before starting treatment, adjust the dose as appropriate based on the initial LDL cholesterol level, treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Due to the increased risk of myopathy, including rhabdomyolysis, use of this medicine at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) For recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment), see below (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Results of controlled clinical trials show that patients with homozygous familial hypercholesterolemia should receive 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In elderly patients, the maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is administered concomitantly to patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg per day. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is administered concomitantly to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg per day. (5) Concomitant administration with other lipid-lowering agents This medicine is effective when administered alone or in combination with a bile acid sequestrant. When this medicine is administered concomitantly with a fibrate (excluding gemfibrozil (see 2. Patients Who Must Not Receive This Medicine under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg per day. (6) Administration to patients with renal impairment Because this medicine is not substantially excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start with an initial dose of 5 mg per day and monitor carefully.
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dosage range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose as appropriate for each patient according to the recommended treatment goals. Allow an interval of 4 weeks or longer between dose adjustments.
This medication can cause serious muscle-related side effects such as myopathy and rhabdomyolysis. The risk of these side effects is particularly higher when taken in high doses. Patients should be cautious. This drug can affect liver function; it should not be taken by patients with liver disease or elevated liver enzyme levels. Women who are pregnant or may become pregnant, as well as nursing women, should also avoid using this medication. The risk of myopathy increases when taken with strong CYP3A4 inhibitors or certain drugs. Patients taking these medications should not use this drug. Patients with a history of alcohol abuse, liver or kidney disease, hypothyroidism, elderly individuals, and women should be particularly cautious when using this medication, and if any muscle pain or weakness occurs, they should consult a physician immediately. This drug can trigger a variety of adverse reactions, particularly muscle pain, gastrointestinal symptoms, headache, and upper respiratory infections. If any adverse reactions are severe or persistent, notify a doctor. Regular monitoring of liver function and muscle condition is recommended during treatment, especially when taken at high doses. As many drugs interact with this medication, medical professionals should be informed of its use when being prescribed new medications. Women who are pregnant or planning to become pregnant should avoid using this medication, and if pregnancy is confirmed while taking it, discontinue use and consult a doctor immediately. It is only to be used in children and adolescents under certain limited circumstances and should not be administered to children under 10 years of age. In case of overdose, seek medical attention immediately for appropriate treatment. This drug should be kept out of reach of children and stored in its original container; avoid transferring it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that is air-tight and kept at room temperature between 1°C and 30°C. Proper storage maintains the drug's effectiveness and prevents degradation.
Brownish-yellow round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Simvastatin 20mg
Tablet · Prescription medication
Daehwa Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.